No deal Brexit could have detrimental impact for four million people in UK living with a rare disease

A letter by ERN GENTURIS member prof Marc Tischkowitz from Cambridge, UK, on the detrimental effects of a no-deal Brexit to rare disease patients in the UK, was published in the Lancet.

The letter has a total of 73 signatories, 54 signatories from UK senior clinicians and researchers who are currently members of an ERN, as well as 19 signatories each representing a patient support group.

You can read it here.

We would appreciate your help in sharing this letter around you!